BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31239240)

  • 1. Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry.
    Sung JM; Martin JW; Jefferson FA; Sidhom DA; Piranviseh K; Huang M; Nguyen N; Chang J; Ziogas A; Anton-Culver H; Youssef RF
    Clin Genitourin Cancer; 2019 Oct; 17(5):e995-e1002. PubMed ID: 31239240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in outcomes for high-grade uterine cancer: A California cancer registry study.
    Baskovic M; Lichtensztajn DY; Nguyen T; Karam A; English DP
    Cancer Med; 2018 Sep; 7(9):4485-4495. PubMed ID: 30123978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010.
    Parise CA; Caggiano V
    BMC Cancer; 2013 Oct; 13():449. PubMed ID: 24083624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and socioeconomic disparities in presentation and outcomes of well-differentiated thyroid cancer.
    Harari A; Li N; Yeh MW
    J Clin Endocrinol Metab; 2014 Jan; 99(1):133-41. PubMed ID: 24243631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival.
    Martin JW; Jefferson FA; Huang M; Sung JM; Chang J; Piranviseh K; Ziogas A; Anton-Culver H; Youssef RF
    Clin Genitourin Cancer; 2020 Jun; 18(3):e330-e336. PubMed ID: 32144047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
    Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
    Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival disparities among African American women with invasive bladder cancer in Florida.
    Brookfield KF; Cheung MC; Gomez C; Yang R; Nieder AM; Lee DJ; Koniaris LG
    Cancer; 2009 Sep; 115(18):4196-209. PubMed ID: 19569251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic and racial disparities in the selection of chest wall boost radiation therapy in californian women after mastectomy.
    Hess C; Lee A; Fish K; Daly M; Cress RD; Mayadev J
    Clin Breast Cancer; 2015 Jun; 15(3):212-8. PubMed ID: 25499694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
    Ou SH; Zell JA; Ziogas A; Anton-Culver H
    Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic and insurance status are independent prognostic indicators of higher disease stage and worse prognosis in bladder cancer.
    Nazemi A; Ghodoussipour S; Pearce S; Bhanvadia S; Daneshmand S
    Urol Oncol; 2019 Oct; 37(10):784-790. PubMed ID: 31076355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities in renal cell carcinoma: a single-payer healthcare experience.
    Mafolasire A; Yao X; Nawaf C; Suarez-Sarmiento A; Chow WH; Zhao W; Corley D; Hofmann JN; Purdue M; Adeniran AJ; Shuch B
    Cancer Med; 2016 Aug; 5(8):2101-8. PubMed ID: 27228559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are There Racial or Socioeconomic Disparities in Ambulatory Outcome or Survival After Oncologic Spine Surgery for Metastatic Cancer? Results From a Medically Underserved Center.
    De la Garza Ramos R; Javed K; Ryvlin J; Gelfand Y; Murthy S; Yassari R
    Clin Orthop Relat Res; 2023 Feb; 481(2):301-307. PubMed ID: 36198109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health disparities and impact on outcomes in children with primary central nervous system solid tumors.
    Austin MT; Hamilton E; Zebda D; Nguyen H; Eberth JM; Chang Y; Elting LS; Sandberg DI
    J Neurosurg Pediatr; 2016 Nov; 18(5):585-593. PubMed ID: 27540957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of Survival for Adolescents and Young Adults with Urothelial Bladder Cancer: Results from the California Cancer Registry.
    Lara J; Brunson A; Keegan TH; Malogolowkin M; Pan CX; Yap S; deVere White R
    J Urol; 2016 Nov; 196(5):1378-1382. PubMed ID: 27208515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic and Survivorship Disparities in Non-muscle-invasive Bladder Cancer in the United States.
    Seo M; Langabeer Ii JR
    J Prev Med Public Health; 2018 Sep; 51(5):242-247. PubMed ID: 30286596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Health Insurance Modify the Association Between Race and Cancer-Specific Survival in Patients with Urinary Bladder Malignancy in the U.S.?
    Morales J; Malles A; Kimble M; Rodriguez de la Vega P; Castro G; Nieder AM; Barengo NC
    Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31540198
    [No Abstract]   [Full Text] [Related]  

  • 18. Racial and Socioeconomic Disparities in Breast Cancer Outcomes within the AJCC Pathologic Prognostic Staging System.
    Kantor O; Wang ML; Bertrand K; Pierce L; Freedman RA; Chavez-MacGregor M; King TA; Mittendorf EA
    Ann Surg Oncol; 2022 Jan; 29(1):686-696. PubMed ID: 34331158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women.
    Martínez ME; Gomez SL; Tao L; Cress R; Rodriguez D; Unkart J; Schwab R; Nodora JN; Cook L; Komenaka I; Li C
    Breast Cancer Res Treat; 2017 Nov; 166(1):185-193. PubMed ID: 28698973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013).
    Weiner AB; Keeter MK; Manjunath A; Meeks JJ
    Urol Oncol; 2018 May; 36(5):237.e9-237.e17. PubMed ID: 29338913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.